Progress in Mind
Choose a channel
Check out the different Progress in Mind content channels.
The challenge of recognizing and managing complications of advanced Parkinson’s disease
Read the full article here.
The challenge of recognizing and managing complications of advanced Parkinson’s disease
Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.
References
1. Antonini A et al. Wearing-off scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011;26(12):2169-75.
2. Aleksovski D et al. Disease progression in Parkinson subtypes: the PPMI dataset. Neurol Sci. 2018;39(11):1971-6.
3. Antonini A et al. Medical and surgical management of advanced Parkinson's disease. Mov Disord. 2018;33(6):900-8.
4. Politis M et al. Parkinson’s disease symptoms: the patient’s perspective. Mov Disord. 2010;25(11):1646-51.
5. Martinez-Martin P et al. Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease. Mov Disord. 2016;31(3):270-9.
6. Martinez-Martin P et al. Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease. Parkinsonism Relat Disord. 2015;21(6):629-34.
7. Rodríguez-Violante M et al. Motor and non-motor wearing-off and its impact in the quality of life of patients with Parkinson's disease. Arq Neuropsiquiatr. 2018;76(8):517-21.
8. Schmitt E et al. The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A pilot study. Mov Disord Clin Pract. 2018;5(3):265-72.
9. Seppi K et al. Update on treatments for nonmotor symptoms of Parkinson’s disease - an evidence-based medicine review. Mov Disord. 2019;34(2):180-98.
10. Mirelman A et al. Gait impairments in Parkinson's disease. Lancet Neurol. 2019;18(7):697-708.
11. Schrag A et al. Predicting diagnosis of Parkinson’s Disease: A risk algorithm based on primary care presentations. Mov Disord. 2019;34(4):480-6.
12. Friederich A et al. Prodromal features of Parkinson's disease: Self-reported symptoms versus clinically assessed signs. Mov Disord. 2019;34(1):144-146.
13. Chastan N and Decker LM. Posturo-locomotor markers of preclinical Parkinson's disease. Neurophysiol Clin. 2019;49(2):173-80.
14. Müller MLTM et al. Treatment options for postural instability and gait difficulties in Parkinson's disease. Expert Rev Neurother. 2019 Aug 30:1-23. doi: 10.1080/14737175.2019.1656067.